The Scientist

» drug manufacturing

Most Recent

image: Novartis Linked to Retracted Papers?

Novartis Linked to Retracted Papers?

By | April 2, 2013

A Japanese newspaper claims that the pharma giant funded flawed research that revealed extra health benefits for one of its top-selling drugs.

0 Comments

image: Regulations for Biosimilars

Regulations for Biosimilars

By | June 1, 2012

As biologic drug patents begin to expire, generic versions will hit the market—but how will they be regulated?

2 Comments

image: Bogus Isomer Vendors Identified

Bogus Isomer Vendors Identified

By | May 25, 2012

Pharma company publishes a list of 17 companies known to have sold the incorrect isomer of the kinase inhibitor bosutinib.

3 Comments

image: Mismarketed Chemical Causes Concern

Mismarketed Chemical Causes Concern

By | May 13, 2012

An incorrect isomer of the kinase inhibitor bosutinib is circulating in the biomedical research community, potentially throwing doubt on study results.

4 Comments

image: A Bill to Expedite Drug Production

A Bill to Expedite Drug Production

By | February 2, 2012

Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.

0 Comments

Advertisement
LI-COR
LI-COR

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Neanderthal-Human Hybrid Unearthed
  3. Sex Differences in Pain Pathway
  4. Antibiotics and the Gut Microbiome
Advertisement
BioLegend
BioLegend
Advertisement
The Scientist